VRX stock


Valeant Pharmaceuticals Intl Inc (VRX) Looks To Pay Down $125M In Debt; Louise Chen Bullish

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced today that it will pay down $125 million of senior secured loans, keeping it on track with …

Ladenburg Sees 35% Upside for Transenterix Inc (TRXC), RBC Gets More Cautious on Valeant Pharmaceuticals Intl Inc (VRX)

Healthcare analysts take different approaches to valuing Transenterix and Valeant.

Cantor Pounds the Table on Valeant Pharmaceuticals Intl Inc (VRX)

Fears about financial control should be a buying opportunity in Valeant stock, says Cantor.

Valeant Pharmaceuticals Intl Inc’s (VRX) Ortho Dermatologics Confirms 2-Year Efficacy For Psoriasis Treatment SILIQ

Valeant Pharmaceuticals Intl Inc’s (NYSE:VRX) Ortho Dermatologics division announced results from the Pivotal Phase 3 long-term extension study (AMAGINE-2), which demonstrated that SILIQ™ (brodalumab) …

Why You Should Hold Your Horses with Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Valeant Pharmaceuticals Intl Inc (VRX)

TEVA needs a long-term solution after MYL’s generic Copaxone approval; VRX works on its debt problem.

Valeant Pharmaceuticals Intl Inc (VRX) Keeps Fighting to Turnaround Debt Overhang, RedHill Biopharma Ltd – ADR (RDHL) Scares Investors to Save $14 Million; Analysts Dive In

Valeant’s comeback progresses with new notes offering; RedHill ups the risk ante in favor of time/money.

Valeant Pharmaceuticals Intl Inc’s (VRX) Bausch + Lomb Launches Biotrue ONEday in Europe

Bausch + Lomb, a division of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), announced the introduction of Biotrue® ONEday for Astigmatism daily disposable contact lenses in 20 …

“Izzy” Englander Gets More Confident on Endocyte, Inc. (ECYT), Ducks Out from Valeant Pharmaceuticals Intl Inc (VRX)

The hedge fund guru’s Q2 moves added ECYT gains to his pocket while saving him greater losses in VRX.

Louise Chen Bucks Odds on Valeant Pharmaceuticals Intl Inc (VRX) to Beat the Street Long-Term, Hedges Bet on Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

A glimpse into why Louise Chen believes Valeant is the better biotech play than Teva down the line.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts